Experts from AWS, Nvidia, and Rescale explore how cloud computing and AI are transforming drug discovery. Learn about protein language models, generative AI, and GPU infrastructure accelerating research from target identification to clinical trials. Discover how these technologies reduce drug development timelines and costs.
Dynamic cloud resources and generative AI are enhancing simulations to bring new treatments to market faster. Discover how AI, including generative AI, can expedite early research and speed up drug discovery and development, using a purpose-built, highly secure, HPC infrastructure in the cloud.
Learn how to:
Overcome challenges around computer-aided drug design (CADD) and high-throughput screening (HTS) with AI-based drug-discovery tools and optimized compute
Use AI-enabled HPC for new drug development such as emulating biological processes, drug development and testing, and drug-target interaction
Scale AI model deployment for drug discovery applications using NVIDIA BioNeMo
Offered Free by: AWS & NVIDIA
See All Resources from: AWS & NVIDIA
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.